Hot
off the Press!![]()
Pet
and Vet News
|
PRESS RELEASE - Pharmacia
Animal Health Launches DURABLE CURE(SM) Program Web Site FOR IMMEDIATE RELEASE Pharmacia Animal
Health Launches DURABLE CURE(SM) Program Web Site The DURABLE CURE(SM) program minimizes repulls associated with BRD, the beef industry's costliest disease challenge. It helps sick animals become high-performing, profitable animals as quickly as possible. "The DURABLE CURE(SM) Web site was designed to provide the beef industry with easy-to-understand information about this management program," says Forrest Roberts, U.S. beef marketing manager with Pharmacia Animal Health. "The beef industry is working harder than ever to produce a consistent, outstanding beef-eating experience, and the DURABLE CURE(SM) program is a critical stepping stone toward achieving that goal." Financial focus The Web site's financial calculator helps managers estimate the cost of repulls in a specific enterprise by examining repulls' impact on medicine costs, labor, reduced weight gain and reduced quality grades. The online calculator uses current Cattle-Fax prices, Texas A&M University Ranch to Rail program data, and USDA carcass premium and discount information. The calculator also helps producers determine the economic benefits of reducing repull rates in their enterprise when using DURABLE CURE(SM). It shows the total annual savings, as well as the annual per-head savings across all cattle marketed. Interactive,
easy to navigate
The DURABLE CURE(SM) Web site offers a solid foundation of both scientific research and practical management techniques. It includes:
Another feature of the site is a link to local Pharmacia Animal Health sales representatives. Producers and veterinarians select their state and county to see contact information for the nearest representative. Pharmacia Animal Health, a division of Pharmacia Corporation, is dedicated to developing products that promote the health of pets and livestock throughout the world. Pharmacia Corporation
(NYSE: PHA) is a leading global pharmaceutical company created through
the merger of Pharmacia & Upjohn with Monsanto Company and
its G.D. Searle unit. Pharmacia has a broad product portfolio, a robust
pipeline of new medicines and an annual investment of more than $2 billion
in pharmaceutical research and development. To receive the contents of this release electronically (including photos or graphics), please contact Shannon Buskohl at SBuskohl@Morganmyers.com or 319-233-0502. CONTACT: Shannon Buskohl See also: |
Hot off the Press Table
of Contents
Do you have news
that we can use? Submit
it here!
Do you have something
to say to the VetMed viewers?
Click here to read the User Agreement and
submit your work!
Have something to say
for all to see right now?
Post it on the board!
New posts to the Veterinary Medicine forums:
Previous Features - Check out other articles from your Guide
Veterinary Medicine Home Page - Main page for VetMed at About.com
Library of Topics - Browse the site library of topics

